APPN vs AVGO

Appian Corporation exhibits strong deterministic health with a Piotroski F-Score of 7/9, indicating solid operational efficiency and financial stability despite lacking an Altman Z-Score for bankruptcy risk assessment. The company demonstrates robust revenue growth at 21.7% YoY and a high gross margin of 72.54%, underpinned by consistent earnings surprises averaging 228% over the last four quarters. However, the stock trades at an extremely high forward P/E of 21.99 and a negative Price/Book of -40.30, reflecting deep market skepticism about current profitability and asset value. While insider sentiment is bearish due to a recent sale, analyst target prices suggest upside potential, though consensus remains weak. The intrinsic value estimate of $0.14 is vastly below current price, signaling a significant premium driven by growth expectations.

Broadcom exhibits a dichotomy between elite operational performance and poor deterministic value metrics. While the Piotroski F-Score of 4/9 indicates stable health, the stock trades at a massive premium to its Graham Number ($44.08) and Intrinsic Value ($151.04). This valuation gap is partially justified by a very attractive PEG ratio (0.68) and strong forward P/E (19.65), suggesting high growth expectations. However, aggressive insider selling by the CEO and CFO, combined with a bearish technical trend, offsets the strong analyst 'strong_buy' consensus.